Possible Proposal of Product Development of Japanese Vaccine, Drug, and Diagnostics for the Control of Infectious Diseases from Academia

INTRODUCTION

The annual JIHS/CCS/DIT Symposium is a key part of the ARO Alliance for Southeast and East Asia (ARISE)’s annual meeting. The symposium this year, co-hosted with Nagasaki University, named as the Joint NU-JIHS Symposium/6th JIHS/CCS/DIT Symposium on Clinical Research and Trials will focus on innovations, policy trends in vaccines, therapeutics, and diagnostics in Japan and overseas, while also highlight the strategies to strengthen international collaboration for infectious disease control in the region.

By attending this symposium, participants will learn more about:
1. Policy trends and strategies for infectious disease control in Japan and globally.
2. Current challenges and innovations in the development of vaccines, drugs, and diagnostics.
3. Clinical trial design and evidence generation, including regional perspectives and best practices.
4. International clinical research and trials networks for infectious diseases in the region.

EVENT INFORMATION

• DATE AND TIME：October 17, 2025, 14:00-16:15 (JST)
• FORMAT：［Onsite］Nagasaki University Campus at Stadium City North
                   ［Online］ZOOM
• LANGUAGE：English
• REGISTRATION：Registration is free. Please register from here
• CONTACT：tawara@nagasaki-u.ac.jp
• FLYER：Download from here

PROGRAM

• Moderators:
• Prof. Kenji Hirayama
• School of Tropical Medicine and Global Health, Nagasaki University, Japan
• Prof. Naoki Hosogaya
• Nagasaki University Hospital, Japan 

• 14:00 Opening remarks
• Prof. Kenji Hirayama
• School of Tropical Medicine and Global Health, Nagasaki University, Japan 

• 14:05-14:25 Speaker 1 + Q&A
• "Advancing Research and Development and Securing Diagnostics, Therapeutics, and Vaccines for Infectious Disease Control in Japan: Policy Trends" 
• Dr. Norio Ohmagari
• Director, Department of Infectious Disease Clinical Policy, Bureau of Health Security and Management/ Specially Appointed Deputy Hospital Director/ Director, Disease Control and Prevention Center,  National Center for Global Health and Medicine, Japan Institute for Health Security, Japan

• 14:25-14:45 Speaker 2 + Q&A
• "Dengue Vaccine Development: Challenges and Innovations" 
• Prof. Kouichi Morita
• Director, Dejima Infectious Disease Research Alliance, Nagasaki University, Japan

• 14:45-15:05 Speaker 3 + Q&A
• "Mycobacterium Control: Innovative Approaches and Challenges in Vaccine and Drug Development"
• Prof. Sohkichi Matsumoto
• Professor, Niigata University School of Medicine, Japan 

• 15:05-15:15 Break

• 15:15-15:35 Speaker 4 + Q&A
• "Clinical Trials and Vaccine Development: A Southeast Asian Perspective"
• Prof. Jarir At Thobari
• Director, Clinical Epidemiology and Biostatistics Unit, Universitas Gadjah Mada, Indonesia

• 15:35-15:55 Speaker 5 + Q&A
• "ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)"
• Prof. David Leslie Paterson
• Director, ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)

• 15:55-16:10 Speaker 6+ Q&A
• ARISE: "International Collaboration and Clinical Trial Network Development for Infectious Disease Research"
• Dr. Daisuke Tokita
• Director, Department of International Trials, Center for Clinical Sciences/ Secretary General ARISE, Japan Institute for Health Security, Japan

• 16:10 -16:15 Closing Remarks
• Prof. Kenji Hirayama
• School of Tropical Medicine and Global Health, Nagasaki University, Japan